Immune Checkpoint Inhibitors (ICIs) on Patients With Hepatitis B Virus Infection: A Promising Approach for Achieving HBsAg Loss
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy · 30.04.2026 · 27 (1) · 1-2
DOI: 10.24871/27120261-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, online erschienen am 30.04.2026. Verfasst von Dolvy Girawan.
Abstract (Originalsprache)
-
Zitieren
APA
Girawan, D. (2026). Immune Checkpoint Inhibitors (ICIs) on Patients With Hepatitis B Virus Infection: A Promising Approach for Achieving HBsAg Loss. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 27(1), 1-2. https://doi.org/10.24871/27120261-2
Vancouver
Girawan D. Immune Checkpoint Inhibitors (ICIs) on Patients With Hepatitis B Virus Infection: A Promising Approach for Achieving HBsAg Loss. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy. 2026;27(1):1-2. doi:10.24871/27120261-2
BibTeX
@article{Girawan2026,
author = {Girawan, Dolvy},
title = {Immune Checkpoint Inhibitors (ICIs) on Patients With Hepatitis B Virus Infection: A Promising Approach for Achieving HBsAg Loss},
journal = {The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy},
year = {2026},
volume = {27},
number = {1},
pages = {1--2},
doi = {10.24871/27120261-2}
}
EUVIMED